CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-20 | Hagen Brett R Chief Accounting Officer | Sale 10b5-1 | −342 | $3.35 | $1K | 128,828 |
| 2023-07-20 | Sinha Vikas See Remarks | Sale 10b5-1 | −1,437 | $3.35 | $5K | 1,184,217 |
| 2023-07-19 | Brainard Diana Chief Executive Officer | Sale 10b5-1 | −8,342 | $3.56 | $30K | 907,299 |
| 2023-07-19 | Hagen Brett R Chief Accounting Officer | Sale 10b5-1 | −342 | $3.56 | $1K | 129,170 |
| 2023-07-19 | Sinha Vikas See Remarks | Sale 10b5-1 | −1,198 | $3.56 | $4K | 1,185,654 |
| 2023-07-05 | Brainard Diana Chief Executive Officer | Sale 10b5-1 | −5,275 | $3.05 | $16K | 915,641 |
| 2023-07-05 | Sinha Vikas See Remarks | Sale 10b5-1 | −2,983 | $3.05 | $9K | 1,186,852 |
| 2023-07-03 | Piccina Cintia Chief Commercial Officer | Grant or award | +147,000 | 147,000 | ||
| 2023-07-03 | Piccina Cintia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +273,000 | 273,000 | ||
| 2023-06-27 | GILEAD SCIENCES, INC. 10% owner | Purchase | +2,930,870 | $3.75 | $11.0M | 16,635,286 |
| 2023-06-09 | Hagen Brett R Chief Accounting Officer | Sale | −5,045 | $5.64 | $28K | 129,512 |
| 2023-05-18 | Brainard Diana Chief Executive Officer | Sale 10b5-1 | −4,536 | $4.21 | $19K | 916,628 |
| 2023-05-11 | Bornstein Jeffrey S Director | Grant or award | +35,000 | 75,197 | ||
| 2023-05-11 | Hallal David Director | Grant or award | +35,000 | 2,108,662 | ||
| 2023-05-11 | Adams Derek N. Director | Grant or award | +35,000 | 35,000 | ||
| 2023-05-11 | Vera Juan Director | Grant or award | +35,000 | 2,374,928 | ||
| 2023-05-11 | Brenner Malcolm Director | Grant or award | +35,000 | 65,197 | ||
| 2023-05-11 | Tomasello Shawn Director | Grant or award | +35,000 | 35,000 | ||
| 2023-05-11 | Jovan-Embiricos Morana Director | Grant or award | +35,000 | 65,197 | ||
| 2023-04-20 | Sinha Vikas See Remarks | Sale 10b5-1 | −1,466 | $3.63 | $5K | 1,185,055 |
Page 9 of 13 · 259 trades